Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Pfizer Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology, and Chris Boshoff, Senior Vice President and Head,... 
Tickers PFE
From Business Wire News Releases
Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression
Today, Pfizer Inc announced it has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health... 
Tickers PFE
From Business Wire News Releases
Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
Tickers PFE
From Business Wire News Releases
Spiriva® HandiHaler® (tiotropium bromide inhalation powder) and COPD Data to be Presented at the 2012 European Respiratory Society (ERS) Congress
Tickers PFE
From Business Wire News Releases
Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions
Tickers PFE
From Business Wire News Releases
Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)
Tickers PFE
From Business Wire News Releases
Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older
Tickers PFE
From Business Wire News Releases
Pfizer Inc and Progenics Alert Physicians and Patients to Information Related to Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging
Tickers PFE PGNX
From Business Wire News Releases
FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations 
Tickers PFE
From Business Wire News Releases
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
Advisory Committee Also Reaffirms the Product’s Safety Profile 
Tickers PFE
From Business Wire News Releases
Pfizer Encourages Families To Bring Their Dogs To This Year’s Holiday Celebration
Tickers PFE
From Business Wire News Releases
FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
Tickers PFE
From Business Wire News Releases
Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases
Tickers PFE
From Business Wire News Releases
Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)
Filing Follows EMEA’s Conclusion that Pfizer’s Program Studying the Use of Lipitor in Children with High Cholesterol is in Compliance with its Requirements 
Tickers PFE
From Business Wire News Releases
Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo
Findings from Pfizer-Sponsored Study Presented as Late-Breaker at American College of Chest Physicians Annual Meeting 
Tickers PFE
From Business Wire News Releases
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease
International Studies to Evaluate Effects of Dimebon in Combination Therapy: One in Patients on Background Donepezil, One in Patients on Background Memantine 
Tickers MDVN PFE
From Business Wire News Releases
Pfizer Completes Consent Solicitation
Tickers PFE
From Business Wire News Releases
Pfizer’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation
Tickers PFE
From Business Wire News Releases
Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend
Tickers PFE
From Business Wire News Releases
New Pfizer Animal Health is Unveiled with Acquisition of Wyeth
Addition of Fort Dodge Animal Health Products Diversifies and Enhances Pfizer’s Already Robust U.S. Portfolio 
Tickers PFE
From Business Wire News Releases
CP-690,550, Pfizer’s Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis
Final Phase 2 Analyses Presented at the American College of Rheumatology/ Association of Rheumatology Health Professionals (ACR/ARHP) Annual Scientific Meeting 
Tickers PFE
From Business Wire News Releases
Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture
Tickers PFE
From Business Wire News Releases
Pfizer And Wyeth Become One: Working Together For A Healthier World™
Added Capabilities, Assets and Talent Advance Pfizer’s Mission to Apply Science and Global Resources to Improve Health and Well Being at Every Stage of Life 
Tickers PFE
From Business Wire News Releases
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
Tickers PFE
From Business Wire News Releases
Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend®
Tickers PFE
From Business Wire News Releases
FDA Advisory Committee Recommends Approval of Pfizer’s Selzentry for Use in Patients Starting HIV Therapy for the First Time
Tickers PFE
From Business Wire News Releases
Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth
Tickers PFE
From Business Wire News Releases
Pfizer Receives Approval from China’s Ministry of Commerce for Pending Wyeth Acquisition
Tickers PFE
From Business Wire News Releases
Frances D. Fergusson And John P. Mascotte Elected To Pfizer’s Board Of Directors
Tickers PFE
From Business Wire News Releases
Pfizer and Eisai Continue Aricept Collaboration
Companies also enter into new collaboration to co-promote Lyrica in Japan 
Tickers PFE
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.